1. Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension
   Zhengqing Ba et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
2. Drugs That Target
   Elaine Vickers, 2018, A Beginner's Guide to Targeted Cancer Treatments CrossRef
3. Pazopanib-induced organizing pneumonia in a patient with leiomyosarcoma: A case report
   Chie Watanabe et al, 2020, Respiratory Medicine Case Reports CrossRef
4. Interstitial Lung Disease Induced by Pazopanib Treatment
   Shotaro Ide et al, 2017, Internal Medicine CrossRef
5. Dermatologic adverse events of Bcr-Abl tyrosine kinase inhibitors
   E. A. Shatokhina et al, 2020, Russian journal of hematology and transfusiology CrossRef
6. More Targets and Treatments
   Elaine Vickers, 2025, A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy CrossRef
7. Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study
   Badr Alharbi et al, 2024, Cureus CrossRef
8. Hypertension and Survival in Renal Cell Carcinoma Treated with anti-VEGFR Agents: A Systematic Review and Meta-Analysis
   Fausto Petrelli et al, 2017, Journal of Onco-Nephrology CrossRef
9. Patient-reported experiences with side effects of kidney cancer therapies and corresponding information flow
   Karin Kastrati et al, 2022, Journal of Patient-Reported Outcomes CrossRef